Trials / Recruiting
RecruitingNCT05943119
Phase II Study of Intensity Modulated Radiotherapy in Dose Painting for Sinus Carcinomas After Endoscopic Surgery
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 52 (estimated)
- Sponsor
- Centre Francois Baclesse · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The patient is randomized to one of the following groups: * Experimental group: Radiotherapy in painting dose on histoscannographic mapping * Control group: standard pan-sinus radiotherapy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Radiotherapy in painting dose on histoscannographic mapping | The target volumes to be delineated are as follows: * High-risk CTV (Clinical Target Volume), corresponding to all initially invaded areas, as identified by comparison between the operative report and the anatomo-pathological report (ideally with histo-surgical mapping). * Low-risk CTV, corresponding to naso-sinusal structures not initially invaded but at risk of recurrence, and located close to the high-risk target volume, including at least 5 mm around the high-risk volume and excluding non-risk areas (muscle, bone). |
| RADIATION | Standard pan-sinusal Radiotherapy | The target volumes to be delineated are as follows: * High-risk CTV, including the entire post-operative cavity, * Low-risk CTV, adapted from the recommendations described by Lapeyre (Cancer/Radiotherapy 2005), and including at least 5 mm around the high-risk volume, excluding non-risk areas (muscle, bone). |
Timeline
- Start date
- 2024-03-11
- Primary completion
- 2028-01-01
- Completion
- 2029-03-01
- First posted
- 2023-07-13
- Last updated
- 2025-07-28
Locations
3 sites across 1 country: France
Source: ClinicalTrials.gov record NCT05943119. Inclusion in this directory is not an endorsement.